Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Adamax vs Selank Amidate: Research Comparison

The following table summarises the core pharmacological, stability, and application differences between Adamax vs Selank Amidate as research tools: Primary Mechanism MC3R/MC4R melanocortin receptor agonist; activates hypothalamic feeding circuits and AMPK meta

This comparison does not assign a generated winner or score.

  • The following table summarises the core pharmacological, stability, and application differences between Adamax vs Selank Amidate as research tools:
  • Primary Mechanism
  • MC3R/MC4R melanocortin receptor agonist; activates hypothalamic feeding circuits and AMPK metabolic pathways
  • GABAergic modulation and monoamine metabolism regulation; influences enkephalin and serotonin/dopamine turnover
  • Non-overlapping mechanisms. Selection depends on whether metabolic or neurotransmitter pathways are research targets
  • Bioavailability Half-Life
  • 4–6 hours; requires twice-daily dosing for sustained receptor occupancy in extended protocols
  • 8–12 hours; amidate modification extends functional window and allows once-daily administration in most research models
  • Selank Amidate's stability advantage reduces dosing frequency and protocol complexity
  • Research Application Context
  • Appetite regulation, energy expenditure, metabolic syndrome models, melanocortin pathway studies, AMPK signalling research
  • Anxiolytic assessment, cognitive performance under stress, GABAergic research, monoamine system studies, stress resilience models
  • Application contexts do not overlap. Each serves distinct research domains
  • Typical Dosing Range
  • 0.5–2.0 mg/kg subcutaneously, once or twice daily depending on protocol duration and endpoint measurement timing
  • 0.1–0.5 mg/kg intraperitoneally or intranasally, typically once daily after initial loading phase in behavioural protocols
  • Dose ranges are not interchangeable due to receptor affinity and potency differences
  • Post-Reconstitution Stability
  • Moderate; 72-hour maximum at 2–8°C before measurable potency loss; pH stable across 5.5–7.5 range
  • Good; 7-day viability at 2–8°C with optimal pH 6.8–7.2; amidate group enhances proteolytic resistance
  • Selank Amidate permits longer working solution storage, reducing preparation frequency in multi-week studies
  • Receptor Selectivity
  • High selectivity for MC4R subtype; minimal activity at MC1R, MC2R, MC5R; does not influence GABA or monoamine systems
  • Multi-system modulation. Affects GABAergic tone, enkephalin levels, and serotonin/dopamine metabolism without melanocortin activity
  • Adamax offers cleaner pathway isolation for melanocortin-specific research; Selank Amidate suits complex neurotransmitter interaction studies
More references

Related material